Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Aducanumab for Alzheimer's Disease
Recruiting2 awardsPhase 3
Santa Ana, California
This trial is testing the safety of aducanumab, a drug that may help clear harmful proteins from the brain, in people who have already taken it. Aducanumab aims to reduce the accumulation of these proteins and slow cognitive impairment in Alzheimer's disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service